-
Views
-
Cite
Cite
M. R. Bani, A. Garofalo, E. Scanziani, R. Giavazzi, Effect of Interleukin-1-beta on Metastasis Formation in Different Tumor Systems, JNCI: Journal of the National Cancer Institute, Volume 83, Issue 2, 16 January 1991, Pages 119–123, https://doi.org/10.1093/jnci/83.2.119
- Share Icon Share
Abstract
Experiments were done to determine the effect of interleukin-1-beta (IL-1β) on metastasis formation in different tumor systems. Intravenous administration of 1 μg of human recombinant IL-1β given 1 hour before tumor cell injection augmented lung colony formation (experimental metastases) by the human A375 melanoma variants, the human HT-29M colon carcinoma, the SN12-K1 renal carcinoma in nude mice, the murine B16 melanoma variants, and the murine UV-2237M fibrosarcoma in syngeneic recipients. The same treatment did not induce lung colony forma tion by a human rectal carcinoma (HCC-P2988) or by a murine reticulum cell sarcoma (M5076), both of which are not metastatic to the lung. Spontaneous metastases were studied in C57BL/6 mice bearing the B16-BL6 melanoma (metastatic to the lung) in their footpad and the M5076 reticulum cell sarcoma (metastatic to the liver) subcutaneously. Daily intraperitoneal treatment with 1 Hg of IL-1β increased lung and liver metastases. These findings indicate that treatment of mice with IL-1β can increase the number of artificial or spontaneous metastases and that this effect is not limited to a single tumor type or to a specific organ. [J Natl Cancer Inst 83:119–123, 1991]
- lung
- fibrosarcoma
- cancer
- intravenous infusion procedures
- reticulosarcoma
- melanoma
- mice, inbred c57bl
- mice, nude
- neoplasm metastasis
- liver
- mice
- neoplasms
- liver metastases
- colon cancer
- rectal carcinoma
- renal carcinoma
- interleukin-1 beta
- intraperitoneal infusion
- intravenous route of drug administration